Physician profile
Jeffrey Morrison
NPI 1174056139
$5,605.56
in general payments reported to CMS, 2019-2025
16 companies · $887 in 2025
The $887 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $185 · 2021: $162 · 2022: $1,544 · 2023: $1,668 · 2024: $1,159 · 2025: $887.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,564 · Grant: $151.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,563.63 |
| Grant | $150.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,960.87 | 2020-2025 | Ams 700, Advantage System, Tactra |
| Endo Pharmaceuticals INC. | $611.80 | 2022-2023 | Xiaflex |
| Antares Pharma, INC. | $512.88 | 2022-2025 | Xyosted, Tlando |
| Coloplast Corp | $322.37 | 2022-2023 | Titan |
| Endo USA, INC. | $252.07 | 2024-2025 | Xiaflex |
| Teleflex LLC | $223.50 | 2023-2024 | Urolift |
| Innovation Technologies INC | $169.59 | 2023-2025 | Irrisept |
| Srs Medical Systems, INC. | $166.56 | 2025 | Urocuff-Dc Disposable, Single, Ct3000 Pro Base Unit |
| Medtronic, INC. | $126.06 | 2022 | |
| Axonics, INC. | $109.02 | 2024 | Bulkamid, Axonics |
| Olympus America INC. | $42.91 | 2025 | Itind System |
| Sumitomo Pharma America, INC. | $26.14 | 2025 | Orgovyx |
| Laborie Medical Technologies Corp. | $25.28 | 2025 | Optilume Bph Drug Coated Balloon Catheter |
| 180 Medical, INC. | $21.79 | 2025 | |
| Halozyme INC | $18.01 | 2023 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urogen Pharma, INC. | $16.71 | 2023 | Jelmyto |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Morrison listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.